GlobeNewswire by notified

Norsk Hydro: Eksklusive utbytte kr 2,50 i dag

Del

Aksjene i Norsk Hydro ASA handles eksklusive utbytte på 2,50 kroner fra og med i dag, 8. mai 2024.


Investorkontakt:
Martine Rambøl Hagen
+47 91708918
Martine.Rambol.Hagen@hydro.com

Denne opplysningen er informasjonspliktig etter verdipapirhandelloven §5-12

Hvis du vil se dette innholdet fra www.globenewswire.com, gi ditt samtykke øverst på denne siden.
Hvis du vil se dette innholdet fra ml-eu.globenewswire.com, gi ditt samtykke øverst på denne siden.

Om GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Følg pressemeldinger fra GlobeNewswire by notified

Registrer deg med din e-postadresse under for å få de nyeste sakene fra GlobeNewswire by notified på e-post fortløpende. Du kan melde deg av når som helst.

Siste pressemeldinger fra GlobeNewswire by notified

Weekly share repurchase program transaction details29.5.2024 18:33:44 CEST | Press release

May 29, 2024 SBM Offshore reports the transaction details related to its EUR65 million (c. US$70 million) share repurchase program for the period May 23, 2024 through May 29, 2024. The repurchases were made under the EUR65 million share repurchase program announced on February 29, 2024 and effective from March 1, 2024. The objective of the program is to reduce share capital. Information regarding the progress of the share repurchase program and the aggregate of the transactions (calculated on a daily basis) for the period March 1, 2024 through May 29, 2024 can be found in the top half of the table below. Further detailed information regarding both the progress of the share repurchase program and all individual transactions can be accessed via the Investors section of the Company’s website. Share Repurchase ProgramOverall progress Share Repurchase Program:Total Repurchase AmountEUR 65,000,000Cumulative Repurchase AmountEUR 21,944,332Cumulative Quantity Repurchased1,553,031Cumulative Ave

Progress on cosmetics plant project: completion of the basic engineering phase and success of the related test campaign29.5.2024 17:45:00 CEST | Press release

PRESS RELEASE Progress on cosmetics plant project: completion of the basic engineering phase and success of the related test campaign Evry, 29 May 2024 – 05:45 p.m.: Global Bioenergies has successfully completed the basic engineering phase of its plant project dedicated to the cosmetics markets whose commissioning is scheduled for mid-2027. The engineering work carried out as part of the basic engineering has precisely defined the each of the units that will enable the fully integrated production of cosmetic-grade isobutene derivatives. It also confirms the project schedule and the nominal CAPEX of 65 million euros (i.e. a maximum CAPEX of 80 million euros taking into account contingencies). Roland Desvignes, Industrial Director of Global Bioenergies, explains: “Two engineering firms have been mandated, the first to handle the biological side, and the second the part dedicated to green chemistry. Their respective expertise gives us a very good vision of the plant's blueprints. We are n

Vaisala Corporation: Share Repurchase 29.5.202429.5.2024 17:30:00 CEST | Press release

VAISALA CORPORATIONSTOCK EXCHANGE RELEASE 29.5.2024Vaisala Corporation: Share Repurchase 29.5.2024In the Helsinki Stock ExchangeTrade date 29.5.2024Bourse trade BuyShare VAIASAmount 500SharesAverage price/ share 39,9700EURTotal cost 19 985,00EURVaisala Corporation now holds a total of 138 828 sharesincluding the shares repurchased on 29.5.2024On behalf of Vaisala CorporationNordea Bank OyjJanne Sarvikivi Sami HuttunenAdditional information Paula Liimattatel +358 9 8949 2020, ir@vaisala.comwww.vaisala.com Vaisala is a global leader in measurement instruments and intelligence for climate action. We equip our customers with devices and data to improve resource efficiency, drive energy transition, and care for the safety and well-being of people and societies worldwide. With almost 90 years of innovation and expertise, we employ a team of over 2,300 experts committed to taking every measure for the planet. Vaisala series A shares are listed on the Nasdaq Helsinki stock exchange.vaisala.com

Thierry Amarger co-opted as independent Director by Vantiva29.5.2024 17:30:00 CEST | Press release

Press Release Thierry Amarger co-opted as independent Director by Vantiva Paris, France – May 29, 2024 – Vantiva (Euronext Paris: VANTI), announced that on the recommendation of the Governance and Social Responsibility Committee, Vantiva's Board of Directors, convened on May 28, 2024, to co-opt Thierry Amarger as an independent Director of Vantiva. He replaces Dominique D'Hinnin, who resigned on April 5, 2024. This co-option took effect immediately. Thierry Amarger's co-option will be submitted to shareholders for ratification at the Annual General Meeting to be held on June 19, 2024. His term of office will expire at the close of the Annual General Meeting for fiscal year 2024. Brian Shearer, Chairman of the Board of Directors, said: “I welcome Thierry Amarger to our Board of Directors. He is a proven leader within multiple areas of the global telecommunications ecosystem, and his skillset will be immediately beneficial to all Vantiva stakeholders.” Mr. Amarger, a French national, is

Zealand Pharma to participate in upcoming healthcare investor conferences in June 202429.5.2024 17:10:00 CEST | Press release

Press release – No. 5 / 2024 Zealand Pharma to participate in upcoming healthcare investor conferences in June 2024 Copenhagen, Denmark, May 29, 2024 – Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology company focused on the discovery and development of innovative peptide-based medicines, today announced that Adam Steensberg, President and CEO, will participate in fireside chats at the following healthcare investor conferences in June: Jefferies Global Healthcare Conference, June 4-6 in New York City Wednesday, June 5 at 10:00 a.m. ET (4:00 p.m. CET) A webcast of the fireside chat will be available at https://wsw.com/webcast/jeff302/register.aspx?conf=jeff302&page=zeal&url=https://wsw.com/webcast/jeff302/zeal/1839808 and accessible through the Events page in the Investor section of Zealand Pharma’s website at https://www.zealandpharma.com/events/ where a replay will also be archived after the fireside chat. Goldman Sachs 45th Annual Global Healthcare Conference, Jun

HiddenA line styled icon from Orion Icon Library.Eye